James J Doherty, Jr

Title: Innovations in Neuroprotection: The Contributions of James J Doherty, Jr.

Introduction

James J Doherty, Jr. is an accomplished inventor based in Landenberg, PA (US). He has made significant contributions to the field of neuroprotection through his innovative research and development of pH-dependent NMDA receptor antagonists. His work focuses on creating neuroprotective drugs that can be utilized in various neurological conditions.

Latest Patents

Doherty holds a patent for pH-dependent NMDA receptor antagonists. These NMDA receptor blockers are designed to serve as neuroprotective drugs that are particularly useful in treating conditions such as stroke, traumatic brain injury, and epilepsy. The invention emphasizes the importance of addressing acidification in brain or spinal cord tissue, which can lead to neurodegeneration. The compounds developed by Doherty exhibit enhanced activity in brain tissue with lower-than-normal pH levels, making them effective in various pathological conditions.

Career Highlights

Doherty's career is marked by his dedication to advancing neuroprotective therapies. He is affiliated with Emory University, where he continues to contribute to research in neurodegenerative diseases. His innovative approach to NMDA receptor inhibition has opened new avenues for treatment in patients suffering from conditions like Parkinson's, Alzheimer's, and ALS.

Collaborations

Throughout his career, Doherty has collaborated with notable colleagues, including Stephen F Traynelis and Dennis C Liotta. These partnerships have further enriched his research and expanded the impact of his inventions in the field of neuroprotection.

Conclusion

James J Doherty, Jr. is a pioneering inventor whose work in developing pH-dependent NMDA receptor antagonists has the potential to transform the treatment landscape for neurodegenerative diseases. His contributions to neuroprotection are invaluable and continue to inspire advancements in medical research.